Available in the shop
- Tesamorelin 2 mg — $88.20
- Tesamorelin 5 mg — $210.00
- Tesamorelin 10 mg — $378.00
- Tesamorelin 20 mg — $735.00
Sold for in vitro laboratory research only — not for human or animal consumption. ≥99% purity specification.
Identification
| Field of research | Sport and recovery |
|---|---|
| Formula | C221H366N72O67S |
| Molecular weight | 5136 g/mol |
| CAS number | 218949-48-5, 804475-66-9 |
| Also known as | TH9507, MQG94M5EEO, TH 9507, tesamorelina, tesamoreline, tesamorelinum, TH-9507, CHEBI:63626, GHRH(1-44), RefChem:57140 |
| PubChem | CID 16137828 |
Summary
Tesamorelin is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010.
From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).
Published research
Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansReviewMayfield CK, Bolia IK, Feingold CL et al. · Am J Sports Med, 2026 · PMID 41476424 · DOI
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
- TesamorelinReview2012 · PMID 31644039
- TesamorelinNewsGrunfeld C, Dritselis A, Kirkpatrick P · Nat Rev Drug Discov, 2011 · PMID 21283099 · DOI
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future PerspectivesReviewRenke G, Chinellato L · Int J Mol Sci, 2026 · PMID 42123471 · DOI
- Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injuryReviewTuffaha SH, Singh P, Budihardjo JD et al. · Expert Opin Ther Targets, 2016 · PMID 27192539 · DOI
- Tesamorelin updateNewspaper ArticleO'Neal R · BETA, 2010 · PMID 21591600
Top 8 of 94 results, by relevance. See all on PubMed.
Search query "Tesamorelin"[Title/Abstract]
Data provenance
| Data | Source | Record |
|---|---|---|
| Chemical identity and structure | PubChem | CID 16137828 |
| Published literature | PubMed | Search on PubMed |
| Summary sentence | Wikipedia | Tesamorelin |
Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.